Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 GELITA Sells R.P. Scherer Shares to Catalent - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

GELITA Sells R.P. Scherer Shares to Catalent

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

GELITA AG has come to an agreement with Catalent Pharma Solutions Inc., Somerset, NJ, the majority shareholder of R. P. Scherer GmbH & Co. KG located in Eberbach, Germany, for acquisition of its 49% shareholding in the company. The completion of the transaction is subject to customary closing conditions including approval from regulatory authorities.

With more than 9000 employees at more than 20 sites, Catalent is a major player in the pharmaceutical industry. For more than 10 years, GELITA AG has treated the shareholding in R.P. Scherer as a purely financial investment and not as part of the core business. The joint venture between GELITA and R.P. Scherer, which was one of the first German-American joint ventures following the Second World War, now comes to an end after more than 60 years. GELITA will continue to provide the R.P. Scherer plant, located on the premises of GELITA AG, with gelatin, energy, steam, fresh water, etc.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters